{"id":79051,"date":"2024-10-14T15:51:35","date_gmt":"2024-10-14T15:51:35","guid":{"rendered":"https:\/\/rnoticias.com.mx\/Portal\/2024\/10\/14\/cofepris-aprueba-nuevo-tratamiento-contra-cancer-de-mama\/"},"modified":"2024-10-14T15:51:35","modified_gmt":"2024-10-14T15:51:35","slug":"cofepris-aprueba-nuevo-tratamiento-contra-cancer-de-mama","status":"publish","type":"post","link":"https:\/\/rnoticias.com.mx\/Portal\/2024\/10\/14\/cofepris-aprueba-nuevo-tratamiento-contra-cancer-de-mama\/","title":{"rendered":"Cofepris aprueba nuevo tratamiento contra cancer de mama"},"content":{"rendered":"<p style=\"margin: 0px 0px 1.25em;padding: 0px;border: 0px;font-size: 16px;line-height: inherit;font-family: Roboto, Helvetica, Arial, sans-serif;vertical-align: baseline;color: #333333\">La Comisi&oacute;n Federal para la Protecci&oacute;n contra Riesgos Sanitarios (Cofepris) ha autorizado el registro sanitario de capivasertib, un medicamento que se utiliza en combinaci&oacute;n con fulvestrant para el tratamiento del c&aacute;ncer de mama avanzado en adultos.<\/p>\n<p style=\"margin: 0px 0px 1.25em;padding: 0px;border: 0px;font-size: 16px;line-height: inherit;font-family: Roboto, Helvetica, Arial, sans-serif;vertical-align: baseline;color: #333333\">Este f&aacute;rmaco ayuda a prevenir la multiplicaci&oacute;n de c&eacute;lulas cancerosas y est&aacute; indicado para pacientes cuyo c&aacute;ncer ha reaparecido o empeorado tras recibir terapia hormonal.<\/p>\n<p style=\"margin: 0px 0px 1.25em;padding: 0px;border: 0px;font-size: 16px;line-height: inherit;font-family: Roboto, Helvetica, Arial, sans-serif;vertical-align: baseline;color: #333333\">El c&aacute;ncer de mama es el tipo m&aacute;s com&uacute;n y la principal causa de muerte por c&aacute;ncer en mujeres a nivel mundial. Aproximadamente el 85% de los casos se presenta en pacientes sin antecedentes familiares, lo que subraya la importancia de diversificar las opciones terap&eacute;uticas, como capivasertib, para abordar esta grave condici&oacute;n.<\/p>\n<p style=\"margin: 0px 0px 1.25em;padding: 0px;border: 0px;font-size: 16px;line-height: inherit;font-family: Roboto, Helvetica, Arial, sans-serif;vertical-align: baseline;color: #333333\">La aprobaci&oacute;n de este medicamento forma parte de un informe quincenal de ampliaci&oacute;n terap&eacute;utica de Cofepris, que report&oacute; 16 nuevos medicamentos, as&iacute; como seis ensayos cl&iacute;nicos y 107 dispositivos m&eacute;dicos. Estos dispositivos incluyen cat&eacute;teres, sistemas de pr&oacute;tesis de cadera, injertos sint&eacute;ticos y mallas quir&uacute;rgicas, entre otros.<\/p>\n<p style=\"margin: 0px 0px 1.25em;padding: 0px;border: 0px;font-size: 16px;line-height: inherit;font-family: Roboto, Helvetica, Arial, sans-serif;vertical-align: baseline;color: #333333\">Adem&aacute;s, se registraron 46 productos diagn&oacute;sticos, como kits para la cuantificaci&oacute;n de transcripciones de fusi&oacute;n relacionadas con el c&aacute;ncer, y se autorizaron 20 equipos m&eacute;dicos, que abarcan concentradores de ox&iacute;geno y sistemas de diagn&oacute;stico por ultrasonido.<\/p>\n<div class=\"google-auto-placed ap_container\" style=\"margin: 0px;padding: 0px;border: 0px;font-size: 16px;line-height: inherit;font-family: Roboto, Helvetica, Arial, sans-serif;vertical-align: baseline;color: #333333;width: 750px;height: auto;clear: both;text-align: center\"><ins class=\"adsbygoogle adsbygoogle-noablate\" style=\"margin: auto;padding: 0px;border: 0px;font: inherit;vertical-align: baseline;background: transparent;height: 90px\" data-ad-format=\"auto\" data-ad-client=\"ca-pub-6543809514106571\" data-adsbygoogle-status=\"done\" data-ad-status=\"filled\"><\/p>\n<div id=\"aswift_5_host\" style=\"margin: 0px;padding: 0px;border: none;font: inherit;vertical-align: baseline;height: 90px;width: 750px;position: relative;background-color: transparent;overflow: visible\">&nbsp;<\/div>\n<p><\/ins><\/div>\n","protected":false},"excerpt":{"rendered":"<p> Cofepris aprueba nuevo tratamiento contra cancer de mama<\/p>\n","protected":false},"author":1,"featured_media":103184,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[172],"tags":[2518],"class_list":["post-79051","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-nacional","tag-cofepris"],"jetpack_featured_media_url":"https:\/\/rnoticias.com.mx\/Portal\/wp-content\/uploads\/2024\/10\/1728946329_como-e-feito-o-tratamento-do-cancer-das-mamas-768x432.jpg","amp_enabled":true,"_links":{"self":[{"href":"https:\/\/rnoticias.com.mx\/Portal\/wp-json\/wp\/v2\/posts\/79051","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rnoticias.com.mx\/Portal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rnoticias.com.mx\/Portal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rnoticias.com.mx\/Portal\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/rnoticias.com.mx\/Portal\/wp-json\/wp\/v2\/comments?post=79051"}],"version-history":[{"count":0,"href":"https:\/\/rnoticias.com.mx\/Portal\/wp-json\/wp\/v2\/posts\/79051\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rnoticias.com.mx\/Portal\/wp-json\/wp\/v2\/media\/103184"}],"wp:attachment":[{"href":"https:\/\/rnoticias.com.mx\/Portal\/wp-json\/wp\/v2\/media?parent=79051"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rnoticias.com.mx\/Portal\/wp-json\/wp\/v2\/categories?post=79051"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rnoticias.com.mx\/Portal\/wp-json\/wp\/v2\/tags?post=79051"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}